OPKO Health Inc OPK:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/07/21 EDT
3.77quote price arrow down-0.03 (-0.79%)
Volume
93,713
Close
3.80quote price arrow down-0.20 (-5.00%)
Volume
9,017,943
52 week range
1.91 - 6.47

...

Loading . . .
  • Open3.92
  • Day High3.93
  • Day Low3.77
  • Prev Close4.00
  • 52 Week High6.47
  • 52 Week High Date07/21/20
  • 52 Week Low1.91
  • 52 Week Low Date05/07/20

Key Stats

  • Market Cap2.547B
  • Shares Out670.16M
  • 10 Day Average Volume4.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.78
  • YTD % Change-3.8

KEY STATS

  • Open3.92
  • Day High3.93
  • Day Low3.77
  • Prev Close4.00
  • 52 Week High6.47
  • 52 Week High Date07/21/20
  • 52 Week Low1.91
  • 52 Week Low Date05/07/20
  • Market Cap2.547B
  • Shares Out670.16M
  • 10 Day Average Volume4.31M
  • Dividend-
  • Dividend Yield-
  • Beta1.78
  • YTD % Change-3.8

RATIOS/PROFITABILITY

  • EPS (TTM)0.19
  • P/E (TTM)20.16
  • Fwd P/E (NTM)31.15
  • EBITDA (MRQ)220.25M
  • ROE (MRQ)7.44%
  • Revenue (MRQ)1.769B
  • Gross Margin (MRQ)36.82%
  • Net Margin (MRQ)6.85%
  • Debt To Equity (MRQ)14.78%

EVENTS

  • Earnings Date07/28/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On OPKO Health Inc

There is no recent news for this security.

Profile

MORE
OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as...
Phillip Frost M.D.
Chairman
Jane Hsiao Ph.D.
Vice Chairman
Adam Logal CPA
Chief Financial Officer
Steven Rubin Esq., J.D.
Executive Vice President
Address
4400 Biscayne Blvd
Miami, FL
33137
United States

Top Peers

SYMBOLLASTCHG%CHG
EBS
Emergent BioSolutions Inc
61.62+0.77+1.27%
SAGE
SAGE Therapeutics Inc
75.07+3.00+4.16%
MYGN
Myriad Genetics Inc
28.25+1.39+5.17%
MEDP
Medpace Holdings Inc
165.28+1.37+0.84%
MYGN
Myriad Genetics Inc
28.25+1.39+5.17%